Literature DB >> 21098016

Mindin: a novel marker for podocyte injury in diabetic nephropathy.

Maki Murakoshi1, Mitsuo Tanimoto, Tomohito Gohda, Shinji Hagiwara, Miyuki Takagi, Satoshi Horikoshi, Yasuhiko Tomino.   

Abstract

BACKGROUND: GeneChip Expression Analysis was employed to survey the glomerular gene expression profile in a type 2 diabetes (T2D) model of KK/Ta mice fed with a high-calorie diet (HC), and we focused on the role of mindin (also called spondin 2), whose expression is upregulated by HC.
METHODS: Isolated glomeruli from three 20-week-old KK/Ta mice fed with HC or a standard diet (SD) were dissected. Total RNA was extracted and labelled for hybridization using the Affymetrix GeneChip Mouse Genome 430 2.0 Array. The gene expression profile was compared between the HC and SD groups using GeneSpring 7.3.1 software. Mindin expression was examined using real-time PCR, western blot analysis and immunohistochemical staining in the glomeruli, cultured podocytes and urine samples of both mice and humans.
RESULTS: Podocyte foot process effacement was observed in mice fed with HC. The mindin protein expression levels in mice were localized in the podocytes, and their levels in the glomeruli were increased in the HC group compared with the SD group. The levels of urinary mindin in the HC group at 16 weeks of age were also significantly higher than those in the SD group although albumin/creatinine ratio (ACR) did not differ between the groups. Furthermore, the levels in patients with T2D were higher than those in healthy individuals and increased gradually with increases in ACR.
CONCLUSIONS: Mindin could be related to podocyte injury and appears to be an early biomarker of the progression of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098016     DOI: 10.1093/ndt/gfq708

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Mindin your own business.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2012-08       Impact factor: 4.599

Review 2.  The Prevalence and Management of Diabetic Nephropathy in Asia.

Authors:  Yasuhiko Tomino; Tomohito Gohda
Journal:  Kidney Dis (Basel)       Date:  2015-04-30

3.  The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.

Authors:  L-F Wang; Y-S Liu; B Yang; P Li; X-S Cheng; C-X Xiao; J-J Liu; S Li; J-L Ren; B Guleng
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

Review 4.  Role of mindin in diabetic nephropathy.

Authors:  Maki Murakoshi; Tomohito Gohda; Mitsuo Tanimoto; Kazuhiko Funabiki; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Exp Diabetes Res       Date:  2011-12-26

5.  Characterization of the early molecular changes in the glomeruli of Cd151 -/- mice highlights induction of mindin and MMP-10.

Authors:  Crystal Naudin; Brian Smith; Danielle R Bond; Matthew D Dun; Rodney J Scott; Leonie K Ashman; Judith Weidenhofer; Séverine Roselli
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

6.  Spondin2 is a new prognostic biomarker for lung adenocarcinoma.

Authors:  Xiaopeng Yuan; Tingting Bian; Jian Liu; Honggang Ke; Jia Feng; Qing Zhang; Li Qian; Xiaoli Li; Yifei Liu; Jianguo Zhang
Journal:  Oncotarget       Date:  2017-07-26

7.  Mindin serves as a tumour suppressor gene during colon cancer progression through MAPK/ERK signalling pathway in mice.

Authors:  Xiao-Shen Cheng; Ya-Ni Huo; Yan-Yun Fan; Chuan-Xing Xiao; Xiao-Mei Ouyang; Lai-Ying Liang; Ying Lin; Jian-Feng Wu; Jian-Lin Ren; Bayasi Guleng
Journal:  J Cell Mol Med       Date:  2020-07-02       Impact factor: 5.310

8.  Differential organ-specific inflammatory response to progranulin in high-fat diet-fed mice.

Authors:  Maki Murakoshi; Tomohito Gohda; Eri Adachi; Saki Ichikawa; Shinji Hagiwara; Yusuke Suzuki
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 9.  A compendium of urinary biomarkers indicative of glomerular podocytopathy.

Authors:  Miroslav Sekulic; Simona Pichler Sekulic
Journal:  Patholog Res Int       Date:  2013-11-13

10.  Saxagliptin Attenuates Albuminuria by Inhibiting Podocyte Epithelial- to-Mesenchymal Transition via SDF-1α in Diabetic Nephropathy.

Authors:  Yun-Peng Chang; Bei Sun; Zhe Han; Fei Han; Shao-Lan Hu; Xiao-Yu Li; Mei Xue; Yang Yang; Li Chen; Chun-Jun Li; Li-Ming Chen
Journal:  Front Pharmacol       Date:  2017-11-01       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.